1. Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy
   Manuela Leo et al, 2022, International Journal of Molecular Sciences CrossRef
2. The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro
   Katrin Pansy et al, 2019, International Journal of Molecular Sciences CrossRef
3. CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?
   Vashendriya V.V. Hira et al, 2020, Biology CrossRef
4. Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy
   Ruogang Zhao et al, 2022, Pharmaceutics CrossRef
5. Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
   Franziska Eckert et al, 2018, Frontiers in Immunology CrossRef
6. Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
   Lei Liu et al, 2023, Frontiers in Immunology CrossRef